These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Neoadjuvant hormone therapy before prostatectomy for cancer localized to the prostate]. Boccon-Gibod L Prog Urol; 1997 Feb; 7(1):97-8. PubMed ID: 9116748 [No Abstract] [Full Text] [Related]
7. [Usefulness and positioning of MAB therapy for prostate cancer]. Akaza H; Chodak GW; Hirao Y Gan To Kagaku Ryoho; 2005 Oct; 32(10):1507-20. PubMed ID: 16227758 [TBL] [Abstract][Full Text] [Related]
8. Carcinoma of the prostate: neoadjuvant hormonotherapy followed by radiotherapy. Scalliet P Acta Urol Belg; 1996 May; 64(2):63-4. PubMed ID: 8701815 [No Abstract] [Full Text] [Related]
11. [Significance of neoadjuvant therapy for prostate cancer]. Okada K; Hachiya T Nihon Hinyokika Gakkai Zasshi; 1997 Sep; 88(9):769-77. PubMed ID: 9364842 [No Abstract] [Full Text] [Related]
12. Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer. Nishimura K; Arichi N; Tokugawa S; Yoshioka I; Kishikawa H; Ichikawa Y Int J Urol; 2007 Mar; 14(3):264-7. PubMed ID: 17430272 [TBL] [Abstract][Full Text] [Related]
13. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer]. Tsukamoto S; Akaza H Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140 [TBL] [Abstract][Full Text] [Related]
15. The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer. Pitts WR BJU Int; 2004 May; 93(7):1119-20. PubMed ID: 15142186 [No Abstract] [Full Text] [Related]
16. Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer. Moul JW Cancer; 2009 Aug; 115(15):3376-8. PubMed ID: 19484788 [No Abstract] [Full Text] [Related]
17. Maximal androgen blockade (MAB) for the treatment of prostate cancer. Kirby RS Br J Clin Pract; 1996; 50(5):287. PubMed ID: 8794610 [No Abstract] [Full Text] [Related]
18. Initiation of LHRH monotherapy for prostate cancer. Milsted RA Prog Clin Biol Res; 1989; 303():69-74. PubMed ID: 2528742 [No Abstract] [Full Text] [Related]
19. [First line therapy in the treatment of metastatic prostate cancer]. Sakai H; Kanetake H Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704 [TBL] [Abstract][Full Text] [Related]
20. Prostate cancer: the role of hormonal therapy. Salesi N; Carlini P; Ruggeri EM; Ferretti G; Bria E; Cognetti F J Exp Clin Cancer Res; 2005 Jun; 24(2):175-80. PubMed ID: 16110748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]